Discovery of a molecular glue promoting CDK12-DDB1 interaction to trigger Cyclin K degradation
Lists
Only you see this
Abstract
Abstract Molecular glues are small molecules that exert their biologic or therapeutic activities by inducing gain-of-function interactions between pairs of proteins. In particular, molecular-glue degraders, which mediate interactions between target proteins and components of the ubiquitin proteasome system to cause targeted protein degradation, hold great promise as a unique modality for therapeutic targeting of proteins that are currently intractable. Here, we report a new molecular glue HQ461 discovered by high-throughput screening of small molecules that inhibited NRF2 activity. Using unbiased loss-of-function and gain-of-function genetic screening followed by biochemical reconstitution, we show that HQ461 acts by promoting interaction between CDK12 and DDB1-CUL4-RBX1 E3 ubiquitin ligase, leading to polyubiquitination and proteasomal degradation of CDK12’s interacting protein Cyclin K (CCNK). Degradation of CCNK mediated by HQ461 compromised CDK12 function, leading to reduced phosphorylation of CDK12 substrate, downregulation of DNA damage response genes, and cell death. Structure-activity relationship analysis of HQ461 revealed the importance of a 5-methylthiazol-2-amine pharmacophore and resulted in an HQ461 derivate with improved potency. Our studies reveal a new molecular glue that engages its target protein directly with DDB1 to bypass the requirement of a substrate-specific receptor, presenting a new strategy for targeted protein degradation.
BibTeX
@inproceedings{lv2020discovery,
author = {Lu Lv and Peihao Chen and Longzhi Cao and Yamei Li and Zhi Jiang Zeng and Yue Cui and Qingcui Wu and Jiaojiao Li and Jianhua Wang and Meng‐Qiu Dong and Xiangbing Qi and Ting Han},
title = {{Discovery of a molecular glue promoting CDK12-DDB1 interaction to trigger Cyclin K degradation}},
booktitle = {eLife},
year = {2020},
doi = {10.7554/elife.59994},
}Loading related content...